Lung Specimen Reference Sets
| Organ | Protocol ID | Reference set title | Cases | Controls | Total participants | Participant groups | Specimen type | Number of specimens | Volume range (mL) | Specimens at NCI-F? | Discovery set? | Follow-up data? | Pathology | Image files | Phase |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lung | 193 | 92 | 286 | Lung Ca Cases & Controls | Serum | 4,257 | 0.05–0.5 | ✓ | | ✓ | A few data elements | CT/PET DICOM | Phase 3 | ||
| | |
|
| | | | Plasma | 4,286 | 0.05–2.0 | | | | | | |
| Lung | Lung Ref Set A Phase 2 Validation (retrospective) (discovery) |
268 | 309 | 577 | | Serum | 3,695 | 0.025–0.5 | ✓ | ✓ | | | | Phase 1 | |
| | |
|
| | | | Plasma | 5,267 | 0.15–0.3 | | | | | | |
| Lung | 86 | 147 | 233 | | Plasma | 3,846 | 0.025–0.375 | ✓ | | | | | Phase 2 | ||
| Lung | 159 | 195 | 354 | | Serum | 6,430 | 0.015–0.2 | ✓ | | | | | Phase 3 | ||
| | |
|
| | | | Plasma | 6,787 | 0.01–0.175 | | | | | | |